WuXi announces licensing agreement with Janssen for TESSA technology

WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of China-based WuXi AppTec, has announced a licensing agre...

August 12, 2022 | Friday | News
BioDuro-Sundia and X-Chem focus on new small molecule drug discovery in China

BioDuro-Sundia, an industry-leading drug discovery, development and commercial service contract research development and...

August 8, 2022 | Monday | News
How CDMOs are Adapting to New mRNA Tech Demands

The COVID-19 pandemic highlighted the successful development and utilisation of mRNA vaccines. This has encouraged bioph...

July 30, 2022 | Saturday | Opinion
WuXi Biologics invests $1.4 B to build comprehensive CRDMO centre in Singapore

WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has announced a ...

July 19, 2022 | Tuesday | News
Samsung Biologics further invests KRW 426 B for Bio Campus 2

Samsung Biologics, a South Korea-based contract development and manufacturing organization (CDMO), has signed a land pur...

July 18, 2022 | Monday | News
TFBS Biosciences expands state-of-the-art facility for viral vector production in Taiwan

TFBS Bioscience Inc., the leading GMP viral vector contract development and manufacturing organization in the Asia-Pacif...

July 15, 2022 | Friday | News
GenScript ProBio partners with DAAN Bio Therapeutics for novel drug discovery

GenScript ProBio, a global CDMO, and South Korea-based startup DAAN Bio Therapeutics, have entered into a strategic...

July 14, 2022 | Thursday | News
Amaran Biotech introduces first fully-automated robotic aseptic filling line in Taiwan

Amaran Biotechnology Inc., a subsidiary of Taiwan's OBI Pharma Inc., has completed the construction of it...

July 13, 2022 | Wednesday | News
WuXi STA opens new large-scale oligonucleotide and peptide manufacturing facility

WuXi STA, a subsidiary of China-based WuXi AppTec, has announced the opening of a new large-scale oligonucleotide and pe...

July 7, 2022 | Thursday | News
Vetter’s newest clinical manufacturing site successfully completed its first customer fills

Next milestone for the site development is achieved        Positive feedback recei...

July 4, 2022 | Monday | News
Fujifilm invests $1.6 B to expand global offering of cell culture manufacturing services

Japan-based Fujifilm Corporation has announced the investment of $1.6 billion to enhance and expand the cell culture man...

July 4, 2022 | Monday | News
WuXi STA opens another high-potency API plant in China

WuXi STA, a WuXi AppTec company, has opened another high-potency API (HPAPI) plant at its Changzhou site (Jiangsu, China...

July 1, 2022 | Friday | News
How Is BioManufacturing Driving APAC CDMO Market?

Companies in the pharmaceutical sector have been facing fierce competition, cost pressure, technological innovations, an...

June 30, 2022 | Thursday | Analysis
Eurofins DiscoverX expands APAC operations with new biotech office in China

Eurofins DiscoverX Products LLC, a global industry leader in products for small and large molecule drug discovery a...

July 4, 2022 | Monday | News
Merck unveils €59 M CDMO facility for critical cancer therapies

Merck has announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients ...

June 24, 2022 | Friday | News
WuXi Biologics launches first commercial drug product facility for pre-filled syringes in China

WuXi Biologics, a global contract research, development and manufacturing organisation (CRDMO) service company, has succ...

June 6, 2022 | Monday | News
Korean firm Hanmi FC to invest 10 billion KRW for building facilities for 'high-tech CDMOs'

South Korea-based Hanmi Fine Chemical, a subsidiary of Hanmi Pharmaceutical Group specializing in APIs (Active Pharmaceu...

May 23, 2022 | Monday | News
Vetter Achieves a Three-Peat in Winning the Best Managed Companies Award

Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family (second from left) along with ...

May 18, 2022 | Wednesday | News
OSZAR »